Therefore, administration of hyperchloremic solutions might well have contributed to the clinically relevant increases in u-NGAL concentrations in some patients observed by Kancir et al. 1 There are no large prospective clinical studies clearly documenting an adverse effect of perioperative administration of hyperchloremic solutions on outcome. Nevertheless, intraoperative infusion of hyperchloremic 0.9% NaCl carries a high potential of inducing hyperchloremic metabolic acidosis, 6 and acute hyperchloremia and hyperchloremic acidosis have numerous adverse effects. 7 It may thus be prudent to avoid the perioperative administration of hyperchloremic solutions altogether whenever possible.
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